Dr. Li is specialized in the design and development of oral, topical and parenteral dosage forms for pharmaceutical and biotechnology products; building on his tenure with Lumosa Therapeutics, TTY Pharmaceuticals, and Standard Chem & Pharm Co. He has hands-on experience in analytical method development, formulation development and CDMO management.

Dr. Li received a Ph.D. in Pharmaceutics from the National Cheng Kung University.